Given our interest in the use of necroptosis as a therapeutic target in HNSCCs, we assessed RIP3 gene expression in HNSCC tumors using the publicly available TCGA HNSCC data set (Figure 5C). Here, RIPK3 is linked to head and neck squamous cell carcinoma.